HSP27 Promotes Cutaneous Squamous Cell Carcinoma Progression by Inhibiting Ferroptosis
BioFactors · 2026
DOI: 10.1002/biof.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2026. Verfasst von Yu-Xin Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Plastic Surgery, Bishan Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Squamous Cell, HSP27 Heat-Shock Proteins, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission.
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (CSCC) is a malignant tumor originating from epidermal keratinocytes. In various types of tumors, ferroptosis is a vital iron‐dependent form of regulated cell death. Recent studies suggest that heat shock protein 27 (HSP27), encoded by the heat shock protein family B member 1 ( HSPB1 ) gene, is involved in the regulation of ferroptosis, but the specific mechanism remains unclear. In this study, CSCC cell lines were transfected with lentivirus‐mediated HSPB1 ‐shRNA or lentivirus carrying overexpressed HSPB1 . CSCC cell lines, xenograft mouse models, and ferroptosis inhibitors or inducers were applied to verify the mechanism and function of HSP27. Downregulation of HSP27 inhibited the proliferation, migration, and invasion of CSCC cells, whereas upregulation of HSP27 showed the opposite results. Similarly, tumor volume and weight were reduced after HSP27 was downregulated in vivo. Further studies revealed that HSP27 promoted the growth of CSCC cells and tumors by inhibiting ferroptosis, and the downregulation of HSP27 enhanced ferroptosis induced by Erastin. Ferrostatin‐1 or Erastin successfully reversed the phenotype triggered by HSP27 alterations. HSP27 can induce the growth of CSCC by inhibiting ferroptosis, and is expected to become a new target for the treatment of CSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Plastic Surgery, Bishan Hospital of Chongqing Medical University, Chongqing, China.
- Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Dermatology, Chongiqng Mylike Medical Cosmetic Hospital, Chongqing, China.
- Department of Dermatology, The First Affiliated Hospital of Chongqing University of Chinese Medicine, Chongqing, China.
- Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Yu-Xin Jiang, Tao Gao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission
Zitieren
APA
Jiang, Y. X., Xu, J., Wang, Z. Y., Gao, T., Chen, A. J., & Cao, Z. R. (2026). HSP27 Promotes Cutaneous Squamous Cell Carcinoma Progression by Inhibiting Ferroptosis. BioFactors. https://doi.org/10.1002/biof.70073
Vancouver
Jiang YX, Xu J, Wang ZY, Gao T, Chen AJ, Cao ZR. HSP27 Promotes Cutaneous Squamous Cell Carcinoma Progression by Inhibiting Ferroptosis. BioFactors. 2026. doi:10.1002/biof.70073
BibTeX
@article{Jiang2026,
author = {Jiang, Yu-Xin and Xu, Jing and Wang, Zi-Yue and Gao, Tao and Chen, Ai-Jun and Cao, Zhen-Rui},
title = {HSP27 Promotes Cutaneous Squamous Cell Carcinoma Progression by Inhibiting Ferroptosis},
journal = {BioFactors},
year = {2026},
doi = {10.1002/biof.70073}
}
EUVIMED